A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder.
Hollander
E
E
Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY.
Stein
D J
DJ
DeCaria
C M
CM
Saoud
J B
JB
Klein
D F
DF
Liebowitz
M R
MR
D000293:Adolescent; D000328:Adult; D000553:Ambulatory Care; D002997:Clomipramine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D010879:Piperazines; D011379:Prognosis; D011388:Prolactin / Q000097:blood*; D012702:Serotonin Antagonists
D010879:Piperazines; D012702:Serotonin Antagonists; D005473:Fluoxetine; D011388:Prolactin; D002997:Clomipramine; C015068:1-(3-chlorophenyl)piperazine